Colon macrophages polarized by commensal bacteria cause colitis and cancer through the bystander effect

Translational Oncology

Volumn 6, Issue 5, 2013, Pages 596-606

  Yang, Yonghong ^a,b   Wang, Xingmin ^a,b   Huycke, Thomas ^a   Moore, Danny R ^a,b   Lightfoot, Stanley A ^b   Huycke, Mark M ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; BETA CATENIN; CYCLOOXYGENASE 2; INTERLEUKIN 10; LIPOSOME; NETRIN 1; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL COLONIZATION; BYSTANDER EFFECT; COLITIS; COLON BIOPSY; COLON CANCER; COMMENSAL; CONTROLLED STUDY; DENDRITIC CELL; ENTEROCOCCUS FAECALIS; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY;

EID: 84885802425     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.13412     Document Type: Article

References (74)

1. Grivennikov SI, Greten FR, and Karin M (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
2. Colotta F, Allavena P, Sica A, Garlanda C, and Mantovani A (2009). Cancerrelated inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30, 1073-1081.
3. Qian BZ and Pollard JW (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51.
4. Gounaris E, Erdman SE, Restaino C, Gurish MF, Friend DS, Gounari F, Lee DM, Zhang G, Glickman JN, Shin K, et al. (2007). Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104, 19977-19982.
5. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15, 1016-1022.
6. Vivier E, Ugolini S, Blaise D, Chabannon C, and Brossay L (2012). Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12, 239-252.
7. Garrett WS, Punit S, Gallini CA, Michaud M, Zhang D, Sigrist KS, Lord GM, Glickman JN, and Glimcher LH (2009). Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 16, 208-219.
8. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, et al. (2012). Adenomalinked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258.
9. Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, Beckhove P, Gounari F, and Khazaie K (2009). T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 69, 5490-5497.
10. +regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 65, 3998-4004.
11. Schaale K, Neumann J, Schneider D, Ehlers S, and Reiling N (2011). Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur J Cell Biol 90, 553-559.
12. Clevers H and Nusse R (2012). Wnt/β-catenin signaling and disease. Cell 149, 1192-1205.
13. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, and Yang SM (2012). Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012, 948098.
14. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, and Smith PD (2005). Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115, 66-75.
15. Tjalsma H, Boleij A, Marchesi JR, and Dutilh BE (2012). A bacterial driverpassenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 10, 575-582.
16. Wang X and Huycke MM (2007). Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 132, 551-561.
17. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, and Huycke MM (2008). Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res 68, 9909-9917.
18. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, et al. (2006). Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355, 873-884.
19. Thun MJ, Jacobs EJ, and Patrono C (2012). The role of aspirin in cancer prevention. Nat Rev Clin Oncol 9, 259-267.
20. Zhou H, Ivanov VN, Gillespie J, Geard CR, Amundson SA, Brenner DJ, Yu Z, Lieberman HB, and Hei TK (2005). Mechanism of radiation-induced bystander effect: role of the cyclooxygenase-2 signaling pathway. Proc Natl Acad Sci USA 102, 14641-14646.
21. Wang D and Dubois RN (2006). Prostaglandins and cancer. Gut 55, 115-122.
22. Speed N and Blair IA (2011). Cyclooxygenase-and lipoxygenase-mediated DNA damage. Cancer Metastasis Rev 30, 437-447.
23. Wang X, Allen TD, Yang Y, Moore DR, and Huycke MM (2013). Cyclooxygenase-2 generates the endogenous mutagen trans-4-hydroxy-2-nonenal in Enterococcus faecalis-infected macrophages. Cancer Prev Res (Phila) 6, 206-216.
24. Wang X, Yang Y, Moore DR, Nimmo SL, Lightfoot SA, and Huycke MM (2012). 4-Hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. Gastroenterology 142, 543-551.
25. Feng Z, Hu W, and Tang MS (2004). Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: a possible mechanism for lipid peroxidation-induced carcinogenesis. Proc Natl Acad Sci USA 101, 8598-8602.
26. Kumagai T, Matsukawa N, Kaneko Y, Kusumi Y, Mitsumata M, and Uchida K (2004). A lipid peroxidation-derived inflammatory mediator: identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages. J Biol Chem 279, 48389-48396.
27. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor ACJ, Buillou PJ, Markham AF, Coletta PL, et al. (2000). Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156, 545-553.
28. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, and Harris CC (1998). Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58, 334-341.
29. Yan B, Wang H, Rabbani ZN, Zhao Y, Li W, Yuan Y, Li F, Dewhirst MW, and Li CY (2006). Tumor necrosis factor-α is a potent endogenous mutagen that promotes cellular transformation. Cancer Res 66, 11565-11570.
30. Yang Y, Wang X, Moore DR, Lightfoot SA, and Huycke MM (2012). TNF-α mediates macrophage-induced bystander effects through netrin-1. Cancer Res 72, 5219-5229.
31. Mehlen P and Guenebeaud C (2010). Netrin-1 and its dependence receptors as original targets for cancer therapy. Curr Opin Oncol 22, 46-54.
32. Paradisi A, Maisse C, Coissieux MM, Gadot N, Lépinasse F, Delloye-Bourgeois C, Delcros JG, Svrcek M, Neufert C, Fléjou JF, et al. (2009). Netrin-1 upregulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci USA 106, 17146-17151.
33. Mazelin L, Bernet A, Bonod-Bidaud C, Pays L, Arnaud S, Gespach C, Bredesen DE, Scoazec JY, and Mehlen P (2004). Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431, 80-84.
34. Kühn R, Löhler J, Rennick D, Rajewsky K, and Müller W (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274.
35. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, and Schwendener RA (2006). Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 95, 272-281.
36. Qualls JE, Kaplan AM, van Rooijen N, and Cohen DA (2006). Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukoc Biol 80, 802-815.
37. Frith JC, Monkkonen J, Blackburn GM, Russell RG, and Rogers MJ (1997). Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5-(β, γ-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res 12, 1358-1367.
38. Cardwell CR, Abnet CC, Veal P, Hughes CM, Cantwell MM, and Murray LJ (2012). Exposure to oral bisphosphonates and risk of cancer. Int J Cancer 131, E717-E725.
39. Thosani N, Thosani SN, Kumar S, Nugent Z, Jimenez C, Singh H, and Guha S (2013). Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol 31, 623-630.
40. Huycke MM, Abrams V, and Moore DR (2002). Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 23, 529-536.
41. Bourgogne A, Garsin DA, Qin X, Singh KV, Sillanpaa J, Yerrapragada S, Ding Y, Dugan-Rocha S, Buhay C, Shen H, et al. (2008). Large scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol 9, R110.
42. Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, and Lichtenstein LM (1990). Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99, 119-124.
43. Nolte H, Spjeldnaes N, Kruse A, andWindelborg B (1990). Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut 31, 791-794.
44. Cheon EC, Khazaie K, Khan MW, Strouch MJ, Krantz SB, Phillips J, Blatner NR, Hix LM, Zhang M, Dennis KL, et al. (2011). Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCΔ468 mice. Cancer Res 71, 1627-1636.
45. Alam R, Kumar D, Anderson-Walters D, and Forsythe PA (1994). Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 152, 1298-1303.
46. Lorimore SA and Wright EG (2003). Radiation-induced genomic instability and bystander effects: related inflammatory-type responses to radiation-induced stress and injury? A review. Int J Radiat Biol 79, 15-25.
47. Wang X and Huycke MM (2011). Long-term exposure of colonic epithelial cells to Enterococcus faecalis-infected macrophages causes cellular transformation. In 10th Annual AACR International Conference on Frontiers in Cancer Prevention Research. American Association for Cancer Research, Boston, MA. p. 109.
48. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, and Sher A (1998). Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12-and gamma interferondependent mechanism. Infect Immun 66, 5157-5166.
49. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, and Sartor RB (2005). Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128, 891-906.
50. Rao CV (2004). Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555, 107-119.
51. Sassa S, Okabe H, Nemoto N, Kikuchi H, Kudo H, and Sakamoto S (2009). Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis. Anticancer Res 29, 4615-4619.
52. Watanabe N, Ikuta K, Okazaki K, Nakase H, Tabata Y, Matsuura M, Tamaki H, Kawanami C, Honjo T, and Chiba T (2003). Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice. Dig Dis Sci 48, 408-414.
53. Fodde R, Smits R, and Clevers H (2001). APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1, 55-67.
54. Mikami T, Mitomi H, Hara A, Yanagisawa N, Yoshida T, Tsuruta O, and Okayasu I (2000). Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitisassociated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer 89, 733-740.
55. Hasselblatt P, Gresh L, Kudo H, Guinea-Viniegra J, and Wagner EF (2008). The role of the transcription factor AP-1 in colitis-associated and β-catenindependent intestinal tumorigenesis in mice. Oncogene 27, 6102-6109.
56. Yoshimi K, Tanaka T, Takizawa A, Kato M, Hirabayashi M, Mashimo T, Serikawa T, and Kuramoto T (2009). Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci 100, 2022-2027.
57. Mees ST, Mennigen R, Spieker T, Rijcken E, Senninger N, Haier J, and Bruewer M (2009). Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and β-catenin. Int J Colorectal Dis 24, 361-368.
58. Castellone MD, Teramoto H, and Gutkind JS (2006). Cyclooxygenase-2 and colorectal cancer chemoprevention: the β-catenin connection. Cancer Res 66, 11085-11088.
59. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM, and Oshima M (2008). Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells. EMBO J 27, 1671-1681.
60. Hallgren J and Gurish MF (2011). Mast cell progenitor trafficking and maturation. Adv Exp Med Biol 716, 14-28.
61. Chichlowski M, Westwood GS, Abraham SN, and Hale LP (2010). Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One 5, e12220.
62. Karlis J, Penttila I, Tran TB, Jones B, Nobbs S, Zola H, and Flesch IE (2004). Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm Bowel Dis 10, 834-847.
63. Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao J, Nunez G, and Zou W (2012). Interleukin-10 ablation promotes tumor development, growth, and metastasis. Cancer Res 72, 420-429.
64. Balish E and Warner T (2002). Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160, 2253-2257.
65. Huycke MM, Moore D, Joyce W, Wise P, Shepard L, Kotake Y, and Gilmore MS (2001). Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol Microbiol 42, 729-740.
66. Winters MD, Schlinke TL, Joyce WA, Glore SR, and Huycke MM (1998). Prospective case-cohort study of intestinal colonization with enterococci that produce extracellular superoxide and the risk for colorectal adenomas or cancer. Am J Gastroenterol 93, 2491-2500.
67. Balamurugan R, Rajendiran E, George S, Samuel GV, and Ramakrishna BS (2008). Real-time polymerase chain reaction quantification of specific butyrateproducing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 23, 1298-1303.
68. Osawa R and Sasaki E (2004). Novel observations of genotypic and metabolic characteristics of three subspecies of Streptococcus gallolyticus. J Clin Microbiol 42, 4912-4913.
69. Darjee R and Gibb AP (1993). Serological investigation into the association between Streptococcus bovis and colonic cancer. J Clin Pathol 46, 1116-1119.
70. Hardwick JCH, van den Brink G, Offerhaus GJ, van Deventer SJH, and Peppelenbosch MP (2001). NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 20, 819-827.
71. Čačev T, Radoševič S, Križanac S, and Kapitanovič S (2008). Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29, 1572-1580.
72. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, Pamukcu R, Moore S, and Lynch RG (2002). Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123, 1527-1542.
73. Deplancke B and Gaskins HR (2001). Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 73, 1131S-1141S.
74. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. (2012). Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123.